United States Genomics Market to Reach $34.62 Billion by 2031, Driven by Genetic Research & Personalized Medicine

Leander, Texas and Tokyo, Japan - Dec.05.2025
As per DataM intelligence research report" Global Genomics Market reached USD 27.9 billion in 2022 and is expected to reach USD 115.4 billion by 2031, growing with a CAGR of 18.7% during the forecast period 2024-2031." Advances in sequencing technologies and personalized medicine are fueling genomics research and applications.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/genomics-market?Prasad

United States: Recent Industry Developments

✅ In November 2025, The FDA approved a new genomic test by Foundation Medicine for comprehensive tumor profiling The test identifies rare fusion genes in solid tumors that can be targeted by newly approved therapies It expands the reach of precision oncology to more cancer patients in the U.S.

✅ In October 2025, Pacific Biosciences launched the "Onso" short-read sequencer with industry-leading accuracy The system uses "sequencing by binding" chemistry to reduce errors in detecting rare variants It challenges the dominance of existing platforms in the U.S. clinical genomics market

✅ In September 2025, 23andMe pivoted its business model to launch a "Total Health" genomic membership service The service offers clinicians-guided interpretation of whole-exome sequencing data for preventative care It moves consumer genomics into the realm of medical-grade health management in the U.S.

✅ In August 2025, Vertex Pharmaceuticals utilized CRISPR-based genomic editing to treat a new cohort of sickle cell patients The ongoing success of the therapy highlights the curative potential of genomic medicine It cements the U.S. position as a leader in gene editing therapies

Japan: Recent Industry Developments

✅ In December 2025, RIKEN launched a new phase of its "Genome Medical Science Project" focused on rare diseases The project aims to sequence the genomes of 100,000 Japanese patients to find diagnostic markers It builds a sovereign genomic database specific to the Japanese population

✅ In November 2025, Genesis Healthcare partnered with a major Japanese life insurer to offer gene-based health advice The collaboration provides policyholders with personalized diet and exercise plans based on their DNA It integrates genomics into the Japanese insurance industry's wellness initiatives

✅ In October 2025, Chugai Pharmaceutical collaborated with Biofourmis to use genomic biomarkers in digital clinical trials The partnership aims to identify patient subgroups that respond best to new cancer drugs It accelerates drug development in Japan through precision patient stratification

✅ In September 2025, Konica Minolta Precision Medicine expanded its "CARE Program" for genetic counseling in Japan The program uses AI to identify individuals at high risk for hereditary cancers It supports the early detection and prevention of cancer in the Japanese healthcare system

Genomics Market: Drivers
The genomics market is expanding rapidly as advancements in DNA sequencing, bioinformatics, and molecular diagnostics transform healthcare and research. Genomic technologies enable personalized medicine, early disease detection, and genetic disorder analysis, improving patient outcomes. Rising investments in R&D, precision medicine, and biotech startups are accelerating innovation. Technological improvements in next-generation sequencing, CRISPR, and high-throughput analysis are enhancing efficiency and accuracy. Growing awareness of personalized health and preventive care is further driving market growth.

Collaboration among academic institutions, healthcare providers, and genomics companies is facilitating development of novel diagnostics and therapeutic strategies. Integration with AI and cloud computing enables complex genomic data interpretation and predictive analytics. Expansion of clinical trials, population genomics programs, and biobanking is broadening applications. Increased accessibility and cost reduction of sequencing technologies support adoption globally. With continuous innovation and rising demand for precision healthcare, the genomics market is poised for sustained growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/genomics-market?Prasad

Genomics Market: Major Players
Agilent Technologies, Bio-Rad Laboratories, Inc., BGI Genomics, Color Genomics, Inc., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., and Myriad Genetics, Inc., among others.

Segment Covered in the Genomics Market:
By Application and Technology
Functional genomics leads with 32% share, driven by its role in understanding gene functions, regulatory networks, and disease mechanisms. Pathway analysis holds 25%, supporting drug target identification and metabolic studies. Biomarker discovery captures 20%, critical for diagnostics, personalized medicine, and therapeutic development. Epigenetics accounts for 15%, enabling research on gene expression regulation and disease epigenomes. Other applications contribute 8%, including pharmacogenomics, comparative genomics, and translational research, expanding insights across diverse biological systems.

By Products and Services
Products dominate with 40% share, encompassing reagents, kits, and sequencing instruments used in genomics research. Services hold 30%, including sequencing, bioinformatics, and laboratory support for large-scale studies. Core genomics services account for 15%, providing specialized high-throughput workflows. Biomarker translation services capture 10%, enabling clinical validation and commercial applications. Computational services contribute 5%, offering AI-driven analysis, data management, and predictive modeling for genomics datasets.

By End User
Pharmaceutical & biotechnology companies lead with 35% share, leveraging genomics for drug discovery, biomarker development, and precision medicine. Clinical research accounts for 25%, supporting trials and translational studies. Academic & government institutes hold 22%, driving basic research, genome annotation, and functional studies. Hospitals & clinics contribute 12%, adopting genomics for diagnostics and personalized patient care. Other end-users represent 6%, including agricultural and environmental research institutions.

Regional Analysis
North America leads with 34% share, supported by strong R&D investments, advanced sequencing infrastructure, and widespread adoption of genomics in clinical and pharmaceutical applications. The U.S. remains the largest contributor, with active government funding and private sector partnerships driving innovation. Europe holds 28%, led by Germany, the UK, and France, emphasizing translational research, biomarker validation, and collaborative genomics initiatives. Asia Pacific captures 26%, fueled by growing biotech ecosystems, sequencing facilities, and research investments in China, Japan, and India. Latin America contributes 6%, focusing on regional research centers and academic collaborations. Middle East & Africa hold 6%, supported by emerging genomics programs, government-backed health initiatives, and increasing adoption of molecular diagnostics.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=genomics-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?Prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.